MBCOF
MARVEL BIOSCIENCES CORPstockOTC
EODNov 18, 2026
0.08USD-11.111%(-0.01)58,500
Loading…
Loading…
3.18M
Healthcare
Biotechnology
HQ
Calgary, AB, Canada
Previous Close
$0.09
Beta
-0.40
52-Week High
$0.17 2026-06-17
52-Week Low
$0.07 2026-10-08
SMA 50
$0.10
SMA 200
$0.13
Avg. Vol 10D
26,360
Avg. Vol 30D
21,026
Avg. Vol 90D
29,782
Relative Vol
2.78
39.79M
Nov 18, 2026
Oct 19, 2026
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site ·
GlobeNewswire Inc.+1 source
Oct 8, 2026
Oct 6, 2026
MBCOF Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.09 | 2026-11-11 | -11.11% | 0.000 |
| 1M | 0.08 | 2026-10-20 | -3.05% | -0.468 |
| 3M | 0.12 | 2026-08-12 | -31.51% | -0.211 |
| 6M | 0.12 | 2026-05-20 | -33.33% | -0.118 |
| 1Y | 0.12 | 2025-11-19 | -35.87% | -0.401 |
| 2Y | 0.11 | 2024-11-25 | -25.62% | — |
| 5Y | 0.07 | 2023-06-23 | +17.30% | -0.031 |
MBCOF Stock Summary
MARVEL BIOSCIENCES CORP (OTC:MBCOF) stock price today is $0.08, and today's volume is 58,500. MBCOF is down 11.111% today. The 30 day average volume is 21,026. MBCOF market cap is $3.18M with 39.79M shares outstanding.